Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark A. Kronenfeld currently holds 12,179 shares of Pacira BioSciences, Inc. (PCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark A. Kronenfeld has been a net seller of PCRX stock. They have purchased $266.4K and sold $597.9K worth of shares.
Mark A. Kronenfeld's most recent insider trade was on Jun 12, 2024, when they sold 12,179 shares at $0.00 per share.
Mark A. Kronenfeld serves as Executive at Pacira BioSciences, Inc. (PCRX). They have executed 20 insider transactions totaling $864.2K over their tenure at the company.
Mark A. Kronenfeld holds the position of Executive at Pacira BioSciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Mark A. Kronenfeld has shown a selling trading pattern, with $266.4K in total purchases and $597.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark A. Kronenfeld was on Jun 8, 2023, when they sold $555.6K worth of PCRX shares. This transaction involved 15,000 shares at $37.04 per share.
Mark A. Kronenfeld currently owns 12,179 shares of Pacira BioSciences, Inc. (PCRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark A. Kronenfeld's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark A. Kronenfeld has 20 Form 4 filings on record as an insider at Pacira BioSciences, Inc..
Set alerts for Mark A. Kronenfeld and 40,000+ other insiders.